T Berney, CH Wassmer, F Lebreton, K Bellofatto… - La Presse médicale, 2022 - Elsevier
Type 1 diabetes is a disease resulting from autoimmune destruction of the insulin-producing beta cells in the pancreas. When type 1 diabetes develops into severe secondary …
AJ Flatt, AJ Peleckis, C Dalton-Bakes… - Diabetes technology …, 2023 - liebertpub.com
Objective: Automated insulin delivery (AID) may benefit individuals with long-standing type 1 diabetes where frequent exposure to hypoglycemia impairs counterregulatory responses …
Y Liu, Q Yu, L Ye, L Yang, Y Cui - Lab on a Chip, 2023 - pubs.rsc.org
Diabetes is a chronic disease affecting 10% of the population globally, and can lead to serious damage in the heart, kidneys, eyes, blood vessels or nerves. Commercial artificial …
Abstract Molecular Communication (MoCo) is a bio-inspired methodology enabling secure communication in “wave-denied” environments like intrabody communication among …
N Tecce, G Cennamo, M Rinaldi, C Costagliola… - Journal of Clinical …, 2024 - mdpi.com
This review addresses the complexities of type 1 diabetes (T1D) and its associated complications, with a particular focus on diabetic retinopathy (DR). This review outlines the …
JG Friedman, K Coyne, G Aleppo… - Endocrine …, 2023 - ec.bioscientifica.com
Hemoglobin A1c (HbA1c) has long been considered a cornerstone of diabetes mellitus (DM) management, as both an indicator of average glycemia and a predictor of long-term …
M Bassi, D Franzone, F Dufour, MF Strati, M Scalas… - Life, 2023 - mdpi.com
Type 1 diabetes (T1D) patients' lifestyle and prognosis has remarkably changed over the years, especially after the introduction of insulin pumps, in particular advanced hybrid closed …
M Jancev, FJ Snoek, GWJ Frederix, H Knottnerus… - BMJ open, 2023 - bmjopen.bmj.com
Introduction The management of type 1 diabetes (T1DM) has undergone significant advancements with the availability of novel technologies, notably continuous and flash …